See also this year's filing and all EDGAR filings for this company.
PDF Report 0001631650_2020_Aimmune_Therapeutics_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001631650')"} |
Graph
Absolute values for 0001631650, Aimmune Therapeutics Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 149,077,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 28,604,000 |
| 3 | remainder_Assets | 26,688,000 |
| 4 | LiabilitiesCurrent | 47,448,000 |
| 5 | LiabilitiesNoncurrent | 52,897,000 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 125,817,000 |
| 9 | ResearchAndDevelopmentExpense | 123,987,000 |
| 10 | remainder_Expenses | 5,632,000 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 6,939,000 |
| 13 | remainder_ComprehensiveNetIncome | 188,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 204,369,000 |
| 1 | Liabilities | 100,345,000 |
| 2 | Expenses | 255,436,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 104,024,000 |
| 5 | NetIncome | -248,497,000 |
| 6 | ComprehensiveNetIncome | -248,403,000 |
| 7 | BaseVar | 283,638,500 |
| 8 | EconomicCapitalRatio | -0.456 |
Edgar->Model Mapping
Feature Distribution
Change over Time
